| scholarly article | Q13442814 |
| P50 | author | Maria B Grant | Q88523403 |
| P2093 | author name string | Lynn C Shaw | |
| Ashay D Bhatwadekar | |||
| P2860 | cites work | Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation | Q22010150 |
| Origins of circulating endothelial cells and endothelial outgrowth from blood | Q24599869 | ||
| Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand | Q24644662 | ||
| Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin | Q28185699 | ||
| Isolation of putative progenitor endothelial cells for angiogenesis | Q28302884 | ||
| Endothelial nitric oxide synthase in vascular disease: from marvel to menace | Q28305279 | ||
| Vision loss among diabetics in a group model Health Maintenance Organization (HMO). | Q30801318 | ||
| Augmentation of postnatal neovascularization with autologous bone marrow transplantation | Q30979202 | ||
| Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment | Q31037844 | ||
| Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy | Q33257976 | ||
| Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial | Q33263365 | ||
| Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells an | Q33290353 | ||
| Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy | Q33303988 | ||
| Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock | Q33590446 | ||
| Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment | Q33701168 | ||
| In vitro differentiation of endothelial cells from AC133-positive progenitor cells. | Q33901656 | ||
| Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance | Q34194262 | ||
| Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence | Q34279059 | ||
| Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. | Q34286784 | ||
| Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. | Q35691127 | ||
| Endothelial function: ready for prime time? | Q35964042 | ||
| IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development | Q35973411 | ||
| Mobilizing endothelial progenitor cells | Q36012003 | ||
| Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry | Q36019443 | ||
| Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst | Q36087920 | ||
| Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone | Q36157326 | ||
| Hyperglycemia in the critically ill. | Q36192332 | ||
| Spotlight on endothelial progenitor cell inhibitors: short review | Q36381012 | ||
| Biology of bone marrow-derived endothelial cell precursors | Q36596218 | ||
| Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: evidence for blunted responsiveness in diabetes | Q36842645 | ||
| Direct evidence of iNOS-mediated in vivo free radical production and protein oxidation in acetone-induced ketosis | Q36846159 | ||
| Oxidative stress impairs endothelial progenitor cell function | Q36953696 | ||
| Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells | Q37101882 | ||
| Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia | Q37131598 | ||
| HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway | Q39946864 | ||
| Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity | Q40718829 | ||
| Endothelial-like cells derived from human CD14 positive monocytes. | Q40863903 | ||
| Changes of inducible protein-10 and regulated upon activation, normal T cell expressed and secreted protein in acute rejection of pancreas transplantation in rats | Q41936711 | ||
| VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells | Q42677798 | ||
| Postprandial elevation of remnant lipoprotein leads to endothelial dysfunction | Q43985731 | ||
| Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. | Q43992605 | ||
| Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization | Q44013450 | ||
| Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase | Q44477052 | ||
| Autologous culture-modified mononuclear cells confer vascular protection after arterial injury | Q44571619 | ||
| Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction | Q44965792 | ||
| Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase | Q45091743 | ||
| Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetes | Q45107570 | ||
| Mild, reversible pancytopenia induced by rosiglitazone | Q46513536 | ||
| Propofol dose-dependently reduces tumor necrosis factor-alpha-Induced human umbilical vein endothelial cell apoptosis: effects on Bcl-2 and Bax expression and nitric oxide generation | Q46513574 | ||
| Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. | Q46592213 | ||
| Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus | Q46651576 | ||
| Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase | Q46979835 | ||
| Immunohistochemical localization of endothelial and inducible nitric oxide synthase within neurons of cattle with rabies | Q47370069 | ||
| Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. | Q47398233 | ||
| Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells | Q48206636 | ||
| Circulating endothelial progenitor cells in malignant gliomas | Q48573661 | ||
| Propofol-induced vascular permeability change is related to the nitric oxide signaling pathway and occludin phosphorylation | Q48610447 | ||
| Protective effects of propofol on lipopolysaccharide-activated endothelial cell barrier dysfunction | Q48641311 | ||
| Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression. | Q50729092 | ||
| Number and adhesive properties of circulating endothelial progenitor cells in patients with in-stent restenosis. | Q51798492 | ||
| Mobilized Endothelial Progenitor Cells by Granulocyte-Macrophage Colony-Stimulating Factor Accelerate Reendothelialization and Reduce Vascular Inflammation After Intravascular Radiation | Q53649329 | ||
| Endothelial progenitor cell culture and differentiation in vitro: a methodological comparison using human umbilical cord blood | Q57384601 | ||
| Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes | Q57790499 | ||
| CD14+CD34 low Cells With Stem Cell Phenotypic and Functional Features Are the Major Source of Circulating Endothelial Progenitors | Q58816263 | ||
| Reduction in Hematocrit and Hemoglobin Following Pioglitazone Treatment is not Hemodilutional in Type II Diabetes Mellitus | Q60462196 | ||
| Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group | Q70215913 | ||
| Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early Treatment Diabetic Retinopathy Study Research Group | Q72028144 | ||
| Nitric oxide activates telomerase and delays endothelial cell senescence | Q73015354 | ||
| Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation | Q73134313 | ||
| Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects | Q73919576 | ||
| CD34- blood-derived human endothelial cell progenitors | Q74236979 | ||
| Role of c-kit/Kit ligand signaling in regulating vasculogenesis | Q79092300 | ||
| Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes | Q79843154 | ||
| Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone | Q80528293 | ||
| Insulin-induced impairment via peroxynitrite production of endothelium-dependent relaxation and sarco/endoplasmic reticulum Ca(2+)-ATPase function in aortas from diabetic rats | Q80550048 | ||
| Endothelial progenitor cells during cerebrovascular disease | Q81089704 | ||
| Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells | Q81110853 | ||
| Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases | Q81168941 | ||
| Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy | Q81767675 | ||
| Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes | Q82097295 | ||
| Differential healing activities of CD34+ and CD14+ endothelial cell progenitors | Q82252418 | ||
| Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells | Q82256218 | ||
| Endothelial progenitor cells and the diabetic paradox | Q82677314 | ||
| P433 | issue | 1 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 29-37 | |
| P577 | publication date | 2010-01-01 | |
| P1433 | published in | Expert review of endocrinology & metabolism | Q26853886 |
| P1476 | title | Promise of endothelial progenitor cell for treatment of diabetic retinopathy | |
| P478 | volume | 5 |
| Q37309486 | Dual Anti-Inflammatory and Anti-Angiogenic Action of miR-15a in Diabetic Retinopathy. |
| Q51161546 | Elevating CXCR7 Improves Angiogenic Function of EPCs via Akt/GSK-3β/Fyn-Mediated Nrf2 Activation in Diabetic Limb Ischemia. |
| Q42372999 | Increased Indoleamine 2,3-Dioxygenase and Quinolinic Acid Expression in Microglia and Müller Cells of Diabetic Human and Rodent Retina |
| Q89100234 | Nrf2 protects against diabetic dysfunction of endothelial progenitor cells via regulating cell senescence |
| Q26852080 | The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding |
Search more.